Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Synthetic Sources is a specialized chemical research and manufacturing organization that provides high-quality chemical building blocks, reagents, and custom synthesis services to the global pharmaceutical and biotechnology sectors. The company focuses on the design and production of complex organic molecules, including heterocyclic compounds, chiral intermediates, and unique functionalized derivatives essential for drug discovery. By offering an extensive catalog of off-the-shelf products alongside tailored contract research and process development services, Synthetic Sources supports clients from early-stage lead optimization through to pilot-scale production. Their core expertise lies in advanced synthetic organic chemistry, enabling the creation of novel chemical entities for medicinal chemistry applications. The firm is recognized for its ability to synthesize rare and difficult-to-source intermediates that facilitate the development of innovative therapeutic candidates.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Synthetic sources.